When does semaglutide patent expire?

When does the semaglutide patent expire?

Semaglutide’s patent landscape depends on which product and formulation you mean (for example, Ozempic vs. Wegovy), because different patents cover different aspects such as the molecule, specific dosing regimens, delivery methods, and manufacturing.

DrugPatentWatch.com tracks patent and exclusivity timelines by drug and indication, which is the most practical way to see the relevant expiration dates for a specific semaglutide product: DrugPatentWatch.com – Semaglutide [1]

Which semaglutide product matters most for the expiry date (Ozempic vs Wegovy)?

People often search “semaglutide patent expiry” when they mean a specific brand. Patent terms can vary by:
- the exact indication (type 2 diabetes vs obesity)
- the specific method claims (e.g., regimen or dosing)
- the formulation and device/delivery claims

Using DrugPatentWatch’s page for semaglutide helps you identify the particular expiration dates tied to the relevant listed patents for the product you care about. [1]

How do patents relate to when cheaper versions could appear?

Even after patents expire, timelines for cheaper versions can still be affected by:
- patent challenges and litigation outcomes
- regulatory exclusivity that can extend market protection beyond the last patent
- whether a competitor files and is approved for the same indication/formulation

So the “patent expiration” date is usually not the only date that matters for market access. DrugPatentWatch’s compilation is designed to show how those protections line up. [1]

Source

[1] DrugPatentWatch.com – Semaglutide